Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rovira, Mercé Boada
NCT05497089: Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome	Completed	2	203	Europe	Temelimab 54mg/kg, Placebo	GeNeuro SA	Post-COVID-19 Syndrome	05/24	05/24
SToMP-AD, NCT04685590: Senolytic Therapy to Modulate the Progression of Alzheimer's Disease () Study	Recruiting	2	48	Europe, US	Dasatinib + Quercetin, Placebo Capsules	Wake Forest University Health Sciences, The University of Texas Health Science Center at San Antonio	Alzheimer Disease, Early Onset, Mild Cognitive Impairment	01/25	01/26